Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,313
Showing 50 of 2,313
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TKNO | Alpha Teknova, Inc. | 13/16 | 8 | 100% | +431.2% | +556.3% | +556.3% | +9.4% |
| 2 | NUTX | Nutex Health Inc. | 10/14 | 7 | 100% | +284.5% | +285.9% | +607.2% | +3.3% |
| 3 | RLMD | Relmada Therapeutics, Inc. | 32/41 | 5 | 66% | +219.5% | +7.0% | +748.2% | -91.0% |
| 4 | SMMT | Summit Therapeutics Inc. | 12 | 4 | 67% | +206.7% | +34.0% | +485.8% | -12.2% |
| 5 | MNPR | Monopar Therapeutics | 24/27 | 11 | 67% | +203.7% | +23.0% | +811.7% | -97.0% |
| 6 | NBY | Novabay Pharmaceuticals, Inc. | 144 | 4 | 81% | +188.9% | +245.9% | +365.5% | -8.2% |
| 7 | LUMN | Lumen Technologies, Inc. | 14/16 | 6 | 100% | +162.4% | +108.7% | +411.6% | +1.7% |
| 8 | GTHP | Guided Therapeutics Inc | 14 | 3 | 93% | +142.4% | +199.4% | +249.4% | -37.5% |
| 9 | VFF | Village Farms International, Inc. | 19/27 | 6 | 95% | +136.7% | +209.9% | +270.9% | -29.1% |
| 10 | STTK | Shattuck Labs, Inc. | 20/28 | 13 | 75% | +133.2% | +63.8% | +325.6% | -71.2% |
| 11 | LIDR | Aeye, Inc. | 25/32 | 8 | 96% | +126.2% | +65.6% | +445.3% | -14.1% |
| 12 | ALMS | Alumis Inc. | 122/154 | 15 | 77% | +124.2% | +201.9% | +345.3% | -59.9% |
| 13 | ACRS | Aclaris Therapeutics, Inc. | 24/36 | 7 | 88% | +121.7% | +115.7% | +249.1% | -71.7% |
| 14 | KERN | Akerna Corp. | 22/31 | 14 | 95% | +120.3% | +87.3% | +240.1% | -247.5% |
| 15 | TOI | Oncology Institute, Inc. | 56/75 | 18 | 73% | +120.0% | +73.7% | +1983.3% | -35.6% |
| 16 | HROW | Harrow Health, Inc. | 19/35 | 5 | 37% | +112.4% | -30.0% | +469.8% | -58.7% |
| 17 | ELDN | Eledon Pharmaceuticals, Inc. | 30 | 10 | 100% | +107.9% | +107.9% | +107.9% | +107.9% |
| 18 | NUVB | Nuvation Bio Inc. | 29/36 | 15 | 72% | +106.6% | +40.5% | +397.7% | -113.8% |
| 19 | PAPL | Pineapple Financial Inc. | 90 | 4 | 67% | +104.0% | +105.0% | +597.8% | -52.5% |
| 20 | PTN | Palatin Technologies Inc | 14/15 | 4 | 93% | +103.6% | +18.8% | +412.4% | -56.5% |
| 21 | GIA | Gigcapital5, Inc. | 16/17 | 7 | 88% | +102.8% | +77.4% | +345.5% | -345.5% |
| 22 | CTM | Castellum, Inc. | 33/46 | 5 | 94% | +102.1% | +21.6% | +701.3% | -2.9% |
| 23 | PROK | Prokidney Corp. | 29 | 5 | 86% | +100.4% | +42.6% | +382.1% | -31.3% |
| 24 | PHAT | Phathom Pharmaceuticals, Inc. | 27/32 | 8 | 59% | +97.9% | +14.6% | +472.1% | -138.4% |
| 25 | EAST | Eastside Distilling, Inc. | 279/285 | 15 | 97% | +96.6% | +83.9% | +234.9% | -91.0% |
| 26 | CERO | Cero Therapeutics Holdings, Inc. | 29 | 5 | 100% | +94.6% | +94.7% | +96.3% | +90.5% |
| 27 | CVI | Cvr Energy Inc | 84/93 | 4 | 100% | +90.7% | +91.6% | +127.7% | +60.6% |
| 28 | CTNT | Cheetah Net Supply Chain Service Inc. | 11 | 6 | 100% | +88.6% | +89.5% | +98.8% | +73.0% |
| 29 | AVTE | Aerovate Therapeutics, Inc. | 58 | 13 | 100% | +87.3% | +91.2% | +93.4% | +36.1% |
| 30 | NAUT | Nautilus Biotechnology, Inc. | 16/20 | 6 | 63% | +87.0% | +62.8% | +296.4% | -25.0% |
| 31 | ICHR | Ichor Holdings, Ltd. | 15/30 | 10 | 93% | +86.6% | +50.7% | +366.1% | -6.0% |
| 32 | MICS | Singing MacHine Co Inc | 26/44 | 6 | 100% | +83.5% | +97.8% | +98.6% | +4.0% |
| 33 | LYRA | Lyra Therapeutics, Inc. | 50/85 | 16 | 100% | +82.0% | +82.6% | +85.1% | +62.9% |
| 34 | CDT | Cdt Equity Inc. | 54 | 7 | 100% | +81.5% | +86.9% | +93.5% | +61.3% |
| 35 | INTG | Intergroup Corp | 20 | 3 | 100% | +81.5% | +94.0% | +106.5% | +15.4% |
| 36 | VELO | Velo3d, Inc. | 89 | 5 | 98% | +78.3% | +78.2% | +224.9% | -19.9% |
| 37 | PRPO | Precipio, Inc. | 22/32 | 5 | 77% | +78.0% | +101.3% | +231.0% | -90.2% |
| 38 | CPIX | Cumberland Pharmaceuticals Inc | 736/934 | 6 | 58% | +77.5% | +18.1% | +403.8% | -65.1% |
| 39 | NANX | Nanophase Technologies Corp | 76/87 | 4 | 91% | +77.5% | +75.0% | +200.0% | -45.8% |
| 40 | AENT | Alliance Entertainment Holding Corp | 22 | 5 | 91% | +77.4% | +68.2% | +165.3% | -21.1% |
| 41 | MULN | Mullen Automotive Inc. | 22/32 | 10 | 91% | +77.4% | +99.3% | +100.0% | -100.0% |
| 42 | BLTH | American Battery Materials, Inc. | 35 | 10 | 63% | +77.1% | +62.5% | +303.6% | -233.3% |
| 43 | GTII | Global Tech Industries Group, Inc. | 27 | 4 | 100% | +76.8% | +77.9% | +97.5% | +59.9% |
| 44 | PRAX | Praxis Precision Medicines, Inc. | 38/43 | 8 | 84% | +75.4% | +111.2% | +111.2% | -95.4% |
| 45 | FOSL | Fossil Group, Inc. | 10/15 | 9 | 100% | +75.2% | +75.6% | +113.7% | +7.4% |
| 46 | BTAI | Bioxcel Therapeutics, Inc. | 49/53 | 8 | 100% | +75.0% | +74.0% | +79.1% | +69.5% |
| 47 | FXLV | F45 Training Holdings Inc. | 32 | 3 | 100% | +74.7% | +75.7% | +81.2% | +65.8% |
| 48 | FTAI | Ftai Aviation Ltd. | 11/16 | 7 | 100% | +73.1% | +74.0% | +111.6% | +16.5% |
| 49 | CLOV | Clover Health Investments, Corp. /De | 25/35 | 9 | 84% | +73.0% | +24.7% | +255.1% | -20.2% |
| 50 | MYCB | My City Builders, Inc. | 13 | 4 | 69% | +72.5% | +26.0% | +194.3% | -26.0% |
Showing 1-50 of 2,313